血液学
医学
内科学
转化研究
干细胞
造血
肿瘤科
髓样
病理
生物
遗传学
作者
Tariq I. Mughal,Naveen Pemmaraju,Rafael Bejar,Robert Peter Gale,Prithviraj Bose,Jean-Jacques Kiladjian,Josef T. Prchal,Daniel J. Royston,Daniel A. Pollyea,Peter Valent,Tim H. Brümmendorf,Tomasz Skorski,Mrinal M. Patnaik,Valeria Santini,Pierre Fenaux,Nicole Kucine,Srdan Verstovsek,Ruben A. Mesa,Tiziano Barbui,G. Saglio,Richard A. Van Etten
摘要
Despite much of the past 2 years being engulfed by the devastating consequences of the SAR-CoV-2 pandemic, significant progress, even breathtaking, occurred in the field of chronic myeloid malignancies. Some of this was show-cased at the 15th Post-American Society of Hematology (ASH) and the 25th John Goldman workshops on myeloproliferative neoplasms (MPN) held on 9th-10th December 2020 and 7th-10th October 2021, respectively. The inaugural Post-ASH MPN workshop was set out in 2006 by John Goldman (deceased) and Tariq Mughal to answer emerging translational hematology and therapeutics of patients with these malignancies. Rather than present a resume of the discussions, this perspective focuses on some of the pivotal translational hematology and therapeutic insights in these diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI